A glimpse about Grifols Egypt in 2024
GEPD key moments and significant milestones achieved during 2024
At Grifols Egypt for Plasma Derivatives (GEPD) we are dedicated to enhancing the health and well-being of all Egyptians by providing access to safe and high-quality lifesaving medicines derived from human plasma.
Plasma derived medicines are unique biological therapies used to treat rare, chronic and, in some cases, life-threatening diseases.
We are building a national world-class integrated plasma infrastructure that will strengthen the country’s healthcare system.
Who we are
About plasma
Donor Centers
Careers
In the Media
The National Plasma Derivatives Project... A Visionary Outlook from President El-Sisi Places Us on the Path to Healthcare Leadership in Africa and the Middle East
April 29, 2025
Gomhoreya Online
A presidential initiative to enhance the healthcare system- the National Project for Plasma Derivatives
October 11, 2024
Al Ahram
Egypt establishes 1st factory for plasma derivatives in New Administrative Capital
October 23, 2023
Egypt Today